EWA
GLSI icon

EverSource Wealth Advisors’s Greenwich LifeSciences GLSI Stock Holding History

EverSource Wealth Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192 Buy
8
+3
+60% +$78 ﹤0.01% 4203
2025
Q4 		$105 Sell
5
-27
-84% -$284 ﹤0.01% 4093
2025
Q3 		$318 Hold
32
– – ﹤0.01% 4044
2025
Q2 		$290 Buy
32
+29
+967% +$276 ﹤0.01% 4007
2025
Q1 		$29 Buy
+3
New +$36 ﹤0.01% 3946

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

EverSource Wealth Advisors's GLSI Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Greenwich LifeSciences (GLSI) stake by 60% in Q1 2026, buying an estimated $78 and bringing the position to 8 shares worth $192. The position accounts for ﹤0.01% of the portfolio, ranked #4203.

EverSource Wealth Advisors first reported a position in GLSI in Q1 2025 and has held it in 5 quarters since. The position peaked at $318 in Q3 2025. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • EverSource Wealth Advisors held 8 shares of Greenwich LifeSciences worth $192 as of Q1 2026.
  • EverSource Wealth Advisors bought 3 Greenwich LifeSciences shares in Q1 2026, an estimated $78.
  • Greenwich LifeSciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #4203 holding.
  • EverSource Wealth Advisors first reported a position in Greenwich LifeSciences in Q1 2025 and has held it in 5 quarters since.
  • EverSource Wealth Advisors's Greenwich LifeSciences position peaked at $318 in Q3 2025.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.